FDA Adverse Event Malfunction Summary report: N

PRECISION®

MDR report key: 2843093 · Received November 21, 2012

Report

Report Number
3006630150-2012-02177
Event Type
Malfunction
Date Received
November 21, 2012
Date of Event
November 2, 2012
Report Date
November 2, 2012
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
030017
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT IS INDICATED THAT THE IPG WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE DEVICE HISTORY RECORDS WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MED WATCH WILL BE FILED.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT'S IPG WAS NOT HOLDING ITS CHARGE. PREMATURE BATTERY DEPLETION WAS SUSPECTED DUE TO ELECTROCAUTERY WAS BEING USED DURING A NON-DEVICE RELATED SURGERY. THE PHYSICIAN ADVISED THE PATIENT FOR AN IPG REPLACEMENT; HOWEVER, THE PATIENT DECIDED NOT TO UNDERGO A POCKET REVISION. MONOPOLAR ELECTROCAUTERY IS A KNOWN SOURCE OF HIGH VOLTAGE TRANSIENT SIGNAL AND CURRENT COMPANY LABELING WARNS AGAINST THE USE OF MONOPOLAR ELECTROCAUTERY. (PHYSICIAN'S IMPLANT MANUAL (B)(4)).

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT THE PATIENT'S IPG WAS NOT HOLDING ITS CHARGE. PREMATURE BATTERY DEPLETION WAS SUSPECTED DUE TO ELECTROCAUTERY WAS BEING USED DURING A NON-DEVICE RELATED SURGERY. THE PHYSICIAN ADVISED THE PATIENT FOR AN IPG REPLACEMENT; HOWEVER, THE PATIENT DECIDED NOT TO UNDERGO A POCKET REVISION. MONOPOLAR ELECTROCAUTERY IS A KNOWN SOURCE OF HIGH VOLTAGE TRANSIENT SIGNAL AND CURRENT COMPANY LABELING WARNS AGAINST THE USE OF MONOPOLAR ELECTROCAUTERY. (PHYSICIAN'S IMPLANT MANUAL 9055940-001).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PRECISION® SPINAL CORD STIMULATOR LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1110 NA

Patients

Seq Age Sex Outcome Treatment
1 65 YR